Medivir doses first subject in Phase Ib study of oncology drug
Swedish biotech company Medivir has dosed the first subject in a Phase Ib study evaluating...
Read More...
Focus:
Sweden
-
Trialbee collaborates with TriNetX for patient-centric trials
Patient recruitment firm Trialbee has partnered with health research network TriNetX for data-driven digital solutions...
Read More...
-
AstraZeneca announces data from BRILINTA independent trial
AstraZeneca has announced that new data from a Phase IV independent trial, TWILIGHT, showed BRILINTA...
Read More...
-
AMRA partners with Micron to expand reach of trials in Japan
Sweden-based AMRA Medical will support its pharmaceutical and research customers in carrying out clinical trials...
Read More...
-
![]()
Trial shows promise for treating PTSD with FAAH inhibitors
A clinical trial by Linköping University in Sweden has shown that a new medication, designed...
Read More...
-
Immunicum reports positive results from Phase II MERECA trial
Immunicum has reported positive results from Phase II Metastatic Renal Cell Carcinoma (MERECA) trial, which...
Read More...
-
InDex reports positive results from Phase IIb trial of cobitolimod
InDex Pharmaceuticals has reported positive results from the Phase IIb CONDUCT trial evaluating cobitolimod for...
Read More...
-
Infant Bacterial enrols first patient in NEC study
Infant Bacterial Therapeutics (IBT) has started enrolling premature infants in the Phase III Connection clinical...
Read More...
-
![]()
Modus Therapeutics initiates Phase I trial of sevuparin injections
Swedish biotech firm Modus Therapeutics has dosed the first cohort of healthy volunteers in its...
Read More...
-
![]()
Immunicum begins ilixadencel combination therapy in ILIAD trial
Pharmaceutical company Immunicum has started dosing patients in the Phase Ib/II ILIAD clinical trial of...
Read More...
